Artimplant presents data on Artelon® for cartilage repair in the knee

Artimplant presents data on Artelon® for cartilage repair in the knee

Västra Frölunda, Sweden, September 29, 2010

A laboratory study (in vitro) and an animal study, which are currently
being presented at the 9th World Congress of the International Cartilage
Repair Society, demonstrate that Artelon® functions as a scaffold for
cells in conjunction with cartilage repair.

Both locally recruited cells obtained through bleeding as well as in
vitro cultured human chondrocytes, which are currently in clinical use,
have been studied. The results show that the newly formed tissue is
improved with the use of Artelon®.

Professor Lars Peterson, Sahlgrenska University Hospital, has led the
animal study:

"There is a considerable clinical need to improve the outcome of
cartilage repair. The studies show the potential that exists in the
Artelon® material as a scaffold and that it contributes to tissue
healing."

Dr. Sebastian Concaro, orthopedic surgeon and also involved in the
animal study:

"The results are very promising and show that the material is well
tolerated in the joint and provides good cartilage repair."

Dr. Katrin Gisselfält, VP Research & Development at Artimplant:

"The results offer good conditions and proof of concept for Artimplant
to develop additional products for the treatment of cartilage injuries."

For further information, please contact: Hans Rosén, CEO, phone 46
(0)31-746 56 00, 46 (0)708 58 34 70,
hans.rosen@artimplant.com (hans.rosen@artimplant.com)

Lars-Johan Cederbrant, CFO, phone 46 (0)31-746 56 54, 46 (0)703 01 68
54,
lars-johan.cederbrant@artimplant.com (lars-johan.cederbrant@artimplant.c
om)

Further information is available at
www.artimplant.com (http://www.artimplant.com). To subscribe to future
press releases please go to
www.artimplant.com/investors-media/subscribe-to-press-releases.html (htt
p://www.artimplant.com/investors-media/subscribe-to-press-releases.html)